Clinical and diagnostic manifestations of tickborne mixed infection in combination with COVID-19.

The coexistence of various pathogens inside the patient's body is one of the poorly studied and current issues. The aim of the study is to identify the relationship between the indicators of complex laboratory diagnostics and the clinical manifestations of a mixed disease during subsequent infection with the SARS-CoV-2 virus using the example of a case of chronic encephalitis-borreliosis infection. Seven blood serum samples were collected from the patient over the course of a year.

Indication Q fever pathogen in the south of Far east.

Q fever (coxiellosis) is a widespread natural focal disease in the world. The causative agent of coxiellosis is the gram-negative bacterium Coxiella burnetii, which is highly contagious and low virulence. The main carriers of C.

Verification of mono- and mixed contaminations transmitting agents tick-borne infections.

In the territory of the Primorsky region, the nosoareas of causative agents of tick-borne infections often coincide and lead to mixed infection of ticks, which causes the mixed pathology in humans . We investigated ixodid ticks taken from people during the epidemic season of 2019 for the spectrum of pathogens of transmissible infections to determine the degree of their mono- and mixed infection. 651 specimens of ixodid ticks investigated.

Inhibitory Activity of Scutellaria baicalensis Flavonoids against Tick-Borne Encephalitis Virus.

We studied virus-inhibiting activity of Baikal skullcap (Scutellaria baicalensis) flavonoids against tick-borne encephalitis virus using various model schemes. The half-maximum cytotoxic concentration (CC) for the plant extract was found (363.9±58.

[Molecular-genetic monitoring as the basis of modern epidemiological surveillance of tick-borne infections.].

Molecular genetic monitoring of natural focal of tick-borne infections in the epidemic season of 2018 revealed infectiousness of ixodid ticks causative agents of tick-borne encephalitis (0.58% of cases), Lyme disease (31% of cases), human monocytic ehrlichiosis (1.6% of cases) and granulocytic anaplasmosis (3.